<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>433</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15277669</PubmedId>
            <Abstract>Abciximab, a derivative of the murine mAb 7E3, protects against ischemic complications of percutaneous coronary interventions by inhibiting ligand binding to the alphaIIbbeta3 receptor. In this study we identified regions on integrin beta3 that control 7E3 binding. Murine/human amino acid substitutions were created in two regions of the betaA domain that previous studies found to influence 7E3 binding: the C177-C184 loop and K125-N133. The T182N substitution and a K125Q mutation reduced 7E3 binding to human beta3 in complex with alphaIIb. The introduction of both the human C177-C184 region and human W129 into murine beta3 was necessary and sufficient to permit 7E3 binding to the human alphaIIb/murine beta3 complex. Although we cannot exclude allosteric effects, we propose that 7E3 binds between C177-C184 and W129, which are within 15 A of each other in the crystal structure and close to the beta3 metal ion-dependent adhesion site. We previously demonstrated that 7E3 binds more rapidly to activated than unactivated platelets. Because it has been proposed that alphaIIbbeta3 changes from a bent to an extended conformation upon activation, we hypothesized that 7E3 binds less well to the bent than the extended conformation. In support of this hypothesis we found that 7E3 bound less well to an alphaIIbbeta3 construct locked in a bent conformation, and unlocking the conformation restored 7E3 binding. Thus, our data are consistent with alphaIIbbeta3 existing in variably bent conformations in equilibrium with each other on unactivated platelets, and activation resulting in alphaIIbbeta3 adopting a more extended conformation.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>13114-20</ArticlePages>
            <ArticleTitle>Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Artoni</LastName>
                    <ForeName>Andrea</ForeName>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>JiHong</ForeName>
                </Author>
                <Author>
                    <LastName>Mitchell</LastName>
                    <ForeName>Beau</ForeName>
                </Author>
                <Author>
                    <LastName>Ruan</LastName>
                    <ForeName>Jian</ForeName>
                </Author>
                <Author>
                    <LastName>Takagi</LastName>
                    <ForeName>Junichi</ForeName>
                </Author>
                <Author>
                    <LastName>Springer</LastName>
                    <ForeName>Timothy A</ForeName>
                </Author>
                <Author>
                    <LastName>French</LastName>
                    <ForeName>Deborah L</ForeName>
                </Author>
                <Author>
                    <LastName>Coller</LastName>
                    <ForeName>Barry S</ForeName>
                </Author>
            </Authors>
            <Affiliations>Laboratory of Blood and Vascular Biology, The Rockefeller University, New York, NY 10021, USA.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Disulfides;Epitopes;Immunoglobulin G;Integrin beta3;Peptide Fragments;Platelet Glycoprotein GPIIb-IIIa Complex</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Substitution; Animals; Antibodies, Monoclonal(metabolism); Disulfides; Epitopes; Humans; Immunoglobulin G(metabolism); Integrin beta3(metabolism); Mice; Peptide Fragments(metabolism); Platelet Glycoprotein GPIIb-IIIa Complex(chemistry; metabolism); Protein Conformation; Species Specificity</ArticleMeshHeadingsList>
            <Journal>
                <Volume>101</Volume>
                <Issue>36</Issue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <Issn>0027-8424</Issn>
                <MedlineTa>Proc Natl Acad Sci U S A</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>β3Hu</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>W155, S156, I157, Q158, N159, C203, Y204, D205, M206, K207, T208, T209, C210</DiscontinuousResidues>
                        <SourceMolecule>
                            <IedbAccession>SRC300</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>76957</EpitopeId>
                <ReferenceRegion>W129, S130, I131, Q132, N133, C177, Y178, D179, M180, K181, T182, T183, C184</ReferenceRegion>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <BCellId>1997</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Unknown</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The antibody 7E3 was provided by David Cheresh (The Scripps Research Institute, La Jolla, CA) --- constructions details are unknown.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>139</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The percentage of 293T cells expressing alphaIIb binding to 7E3 as juged by flow cytometry was 46% +/- 17.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>7E3</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>β3Hu</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <IedbAccession>SRC300</IedbAccession>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Internal Identifier-no external match available</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 2</LocationOfData>
                        <BCellId>1994</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Unknown</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The antibody 10E5 was provided by David Cheresh (The Scripps Research Institute, La Jolla, CA) --- constructions details are unknown.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>139</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The percentage of 293T cells expressing alphaIIb binding to 10E5 as measured by flow cytometry was 42% +/- 12.  The antigen in this assay was the β3Hu epitope expressed in 293T cells.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>10E5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>β3Hu</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <IedbAccession>SRC300</IedbAccession>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Internal Identifier-no external match available</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <TransfectedCell>
                                    <SubType>Transfected Cell</SubType>
                                    <CellType>293-T-Epithelial cell</CellType>
                                </TransfectedCell>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

